Evidence map›Paper›PMID 39187600›Full record

ArticleBone marrow transplantation2024

Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation.

Shigeo Fuji, Hirohisa Nakamae, Junichi Sugita, Yuho Najima, Tatsuya Konishi, Takashi Tanaka, Yasuhiro Nakashima, Mitsutaka Nishimoto, Hiroshi Okamura, Kazutaka Nakayama and 6 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shigeo Fuji *Department of Hematology, Osaka International Cancer Institute, Osaka, Japan. fujishige1231@gmail.com.ORCID http://orcid.org/0000-0001-5118-7950
Hirohisa Nakamae *Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0003-4203-990X
Junichi SugitaDepartment of Hematology, Sapporo Hokuyu Hospital, Hokkaido, Japan.ORCID http://orcid.org/0000-0003-3852-5075
Yuho NajimaHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8910-0021
Tatsuya KonishiDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Matsuyama, Ehime, Japan.ORCID http://orcid.org/0000-0001-6203-9435
Takashi TanakaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Yasuhiro NakashimaDepartment of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0003-3025-723X
Mitsutaka NishimotoDepartment of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0002-0388-3836
Hiroshi OkamuraDepartment of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.
Kazutaka NakayamaDepartment of Hematology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan.
Ayumu ItoDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Matsuyama, Ehime, Japan.ORCID http://orcid.org/0000-0001-5681-6357
Makoto YoshimitsuDepartment of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.ORCID http://orcid.org/0000-0002-5935-0385
Masayuki HinoDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Takahiro FukudaDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Matsuyama, Ehime, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.ORCID http://orcid.org/0000-0003-4404-2870
Kimikazu YakushijinDepartment of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.ORCID http://orcid.org/0000-0003-2511-7857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39187600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.